Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rongyuan Zhuang
Observed names:
Rong-Yuan Zhuang; Tao Li; Yuan-Ting Zheng; Wei-Min Cai,
Rong-yuan Zhuang,
RongYuan Zhuang,
Rong‐Yuan Zhuang,
Zhuang, Rongyuan
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Zhongshan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Xiamen University,
Fudan University,
Zhongshan Hospital,
The First Affiliated Hospital, Sun Yat-sen University,
Xiamen University of Technology
show all 6
ORCID:
0000-0002-2787-6446
Observed ORCID:
0000-0002-2787-6446
OpenAlex ID:
A5113447042
Do renin–angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients? Evidence from a meta-analysis including 55 studies
2017
·
Hong Sun
, Tao Li
, et al.
·
Medicine
·
100
Alphalipoic Acid Prevents Oxidative Stress and Peripheral Neuropathy in Nab-Paclitaxel-Treated Rats through the Nrf2 Signalling Pathway
2019
·
Hong Sun
, Xi Guo
, et al.
·
Oxidative Medicine and Cellular Longevity
·
52
PDF
Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis
2019
·
Xi Guo
, Hong Sun
, et al.
·
Critical Reviews in Oncology/Hematology
·
42
Activity of PD-1 Inhibitor Combined With Anti-Angiogenic Therapy in Advanced Sarcoma: A Single-Center Retrospective Analysis
2021
·
Yang You
, Xi Guo
, et al.
·
Frontiers in Molecular Biosciences
·
35
Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma
2020
·
Zhi‐Ming Wang
, Shi‐Long Zhang
, et al.
·
Cancer Medicine
·
34
PDF
The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis
2017
·
Rongyuan Zhuang
, Song Li
, et al.
·
PLoS ONE
·
33
PDF
K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis
2016
·
Tao Li
, Yuanting Zheng
, et al.
·
Medical Oncology
·
32
Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy
2016
·
Zhiming Wang
, Li Liang
, et al.
·
Cellular Physiology and Biochemistry
·
31
High incidence of severe neutropenia after gemcitabine-based chemotherapy in Chinese cancer patients with CDA 79A>C mutation
2012
·
Jialin Xu
, Yuhong Zhou
, et al.
·
Clinica Chimica Acta
·
24
Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial
2022
·
Zhi-ming Wang
, Rong-yuan Zhuang
, et al.
·
Clinical Cancer Research
·
23
PDF
SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer
2018
·
Yiyi Yu
, Ke Peng
, et al.
·
Oncology Reports
·
21
PDF
Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma
2020
·
Wenshuai Liu
, Hanxing Tong
, et al.
·
BMC Cancer
·
20
PDF
A multicenter, phase 1 study of AB011, a recombinant humanized anti-CLDN18.2 monoclonal antibody, as monotherapy and combined with capecitabine and oxaliplatin (CAPOX) in patients with advanced solid tumors.
2023
·
Jin Li
, Hongming Pan
, et al.
·
Journal of Clinical Oncology
·
17
Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing
2020
·
Chenlu Zhang
, Zhiming Wang
, et al.
·
OncoTargets and Therapy
·
17
PDF
Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX)
2016
·
Yan Wang
, Rong-yuan Zhuang
, et al.
·
Oncotarget
·
15
PDF
Liposarcoma miRNA Signatures Identified from Genome-Wide miRNA Expression Profiling
2014
·
Yuhong Zhou
, Yong Zhang
, et al.
·
Future Oncology
·
15
An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients
2018
·
Li Liang
, Jiawen Tian
, et al.
·
Cellular Physiology and Biochemistry
·
12
PDF
Prognostic factors in patients with recurrent or metastatic retroperitoneal leiomyosarcoma
2015
·
Qian Li
, Rongyuan Zhuang
, et al.
·
Future Oncology
·
11
[A pilot study of chemotherapy combined with intraperitoneal perfusion of cytokine-induced killer cells for advanced gastric cancer patients with ascites].
2013
·
Zhi-ming Wang
, Rong-yuan Zhuang
, et al.
·
PubMed
·
10
Establishing a patient-derived xenograft model of human myxoid and round-cell liposarcoma
2017
·
Yiming Qi
, Yu Hu
, et al.
·
Oncotarget
·
9
PDF
A novel long noncoding RNA PILRLS promote proliferation through TCL1A by activing MDM2 in Retroperitoneal liposarcoma
2017
·
Yebo Shao
, Yong Zhang
, et al.
·
Oncotarget
·
9
PDF
Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN
2022
·
Xi Guo
, Suyao Li
, et al.
·
Frontiers in Oncology
·
8
PDF
Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28
2018
·
Chuan Tian
, Haifeng Ying
, et al.
·
Cancer Management and Research
·
7
PDF
No association Between Calcium Channel Blockers and Survival in Patients with Cancer: A systematic Review and Meta-analysis
2016
·
Sun, Hong
, Rong-Yuan Zhuang; Tao Li; Yuan-Ting Zheng; Wei-Min Cai
·
PubMed
·
7
Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3
2019
·
Yong Zhang
, Hanxing Tong
, et al.
·
Cell Death and Disease
·
6
PDF
Show more works
View as search
Works count:
60
Citation count:
622
H-index:
15
I10-index:
19
Year
Topic
Type